Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 257

The DOI matches its Crossref record.

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.

Open access
Levine, T B, Franciosa, J A, Cohn, J N·1980·Circulation

Abstract

Captopril (SQ 14,225), an oral angiotensin converting-enzyme inhibitor, was administered to 11 patients with severe congestive heart failure (CHF).Peak effect was observed at 1.5 hours after administration.At peak effect right atrial pressure fell from 3.4 to 0.0 mm Hg, pulmonary capillary wedge pressure (PCW) fell from 22.7 to 12.3 mm Hg, mean arterial pressure (MAP) fell from 79.5 to 62.1 mm Hg, systemic vascular resistance (SVR) fell from 1989 to 1370 dyn-sec-cm-5, pulmonary vascular resistance fell from 843 to 523 dyn-sec-cm-, and cardiac index (CI) rose from 1.96 to 2.43 1/min/m2.These were all statistically significant.Control plasma renin activity (PRA) was elevated (25.9 ng/ml/hr) and correlated with resting PCW (r = 0.65).The acute hemodynamic response was related to PRA: a fall in MAP (r = 0.74), a fall in PCW (r = 0.80), a fall in SVR (r = 0.45) and a rise in CI (r = 0.45).Eight patients were placed on chronic captopril therapy.After 2 or more months, their exercise time was significantly increased, from 6.8 to 11.7 minutes.Their cardiothoracic ratios showed a significant decrease, from 0.55 to 0.52, and most patients reported symptomatic improvement.Chronic response was not predicted by acute hemodynamic response.Captopril is therefore a vasodilator with both arterial and venous effects that are at least partially caused by inhibition of the renin-angiotensin system.It may be useful for the treatment of CHF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.62.1.35

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 257

Metadata

Authors
Levine, T. B., Franciosa, J. A., & Cohn, J. N.
Venue
Circulation
Published
1980-07
Volume
62
Issue
1
Pages
35-41
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2063484017
Cited by
257
References
0
FWCI
29.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. https://app.cochat.ai/papers/10.1161/01.cir.62.1.35
The paper
Levine, T. B., Franciosa, J. A., & Cohn, J. N. (1980). Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation. https://doi.org/10.1161/01.cir.62.1.35

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.